Named as a key player in 132 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Healthcare In Vitro Diagnostic | Healthcare Services | $83.5 Bn | 3.8% |
| Point of Care Diagnostics | Digital Health | $45.4 Bn | 7.4% |
| Nursing Education | Healthcare Services | $10.3 Bn | 8.1% |
| Bone Cancer Diagnostic | Healthcare Services | $1.1 Bn | 7.4% |
Named as key players in the same markets as Becton, Dickinson and Company (BD) (number of shared markets).
Roche Diagnostics4 shared markets
Siemens Healthineers4 shared markets
Abbott Laboratories3 shared markets
bioMérieux SA3 shared markets
Danaher Corporation2 shared markets
Ortho Clinical Diagnostics2 shared markets
Thermo Fisher Scientific Inc.2 shared markets
Amgen Inc.1 shared market
Search all reports for Becton, Dickinson and Company (BD) All companies